During dozens of drug shortages, which include cancer medications, emergency treatments and 14 others after a U.S. pharma company closed, the FDA drafted a guidance asking manufacturers to alert the agency on drug supply disruptions.
Read the full post on Becker's Hospital Review - Healthcare News
